A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy
Public ClinicalTrials.gov record NCT02819323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02819323
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Braintree Laboratories
- Industry
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Interventions
- PEG-ELS Drug
- BLI800 Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2016
- Primary completion
- Mar 26, 2018
- Completion
- Mar 26, 2018
- Last update posted
- May 2, 2021
2016 – 2018
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Braintree Research Site 27 | Mobile | Alabama | 36582 | — |
| Braintree Research Site 30 | Tucson | Arizona | 85724 | — |
| Braintree Research Site 23 | Orange | California | 92868 | — |
| Braintree Research Site 16 | San Francisco | California | 94158 | — |
| Braintree Research Site 5 | Gainesville | Florida | 32610 | — |
| Braintree Research Site 24 | Jacksonville | Florida | 32207 | — |
| Braintree Research Site 21 | Orlando | Florida | 32806 | — |
| Braintree Research Site 2 | Atlanta | Georgia | 30342 | — |
| Braintree Research Site 13 | Chicago | Illinois | 60611 | — |
| Braintree Research Site 3 | Park Ridge | Illinois | 60068 | — |
| Braintree Research Site 26 | Indianapolis | Indiana | 46202 | — |
| Braintree Research Site 25 | Minneapolis | Minnesota | 55454 | — |
| Braintree Research Site 18 | Rochester | Minnesota | 55905 | — |
| Braintree Research Site 1 | Flowood | Mississippi | 39232 | — |
| Braintree Research Site 9 | Buffalo | New York | 14222 | — |
| Braintree Research Site 28 | New York | New York | 10021 | — |
| Braintree Research Site 19 | New York | New York | 10032 | — |
| Braintree Research Site 32 | The Bronx | New York | 10467 | — |
| Braintree Research Site 6 | Pittsburgh | Pennsylvania | 15224 | — |
| Braintree Research Site 20 | Memphis | Tennessee | 38103 | — |
| Braintree Research Site 34 | Plano | Texas | 75093 | — |
| Braintree Research Site 22 | Salt Lake City | Utah | 84118 | — |
| Braintree Research Site 10 | Burlington | Vermont | 05401 | — |
| Braintree Research Site 17 | Norfolk | Virginia | 23507 | — |
| Braintree Research Site 4 | Roanoke | Virginia | 24013 | — |
| Braintree Research Site 11 | Seattle | Washington | 98105 | — |
| Braintree Research Site 14 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02819323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 2, 2021 · Synced Jun 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02819323 live on ClinicalTrials.gov.